Literature DB >> 181189

The effects of cyclic AMP on leucocyte inhibitory factor (LIF) production and on the inhibition of leucocyte migration.

R Lomnitzer, A R Rabson, H J Koornhof.   

Abstract

The effect of drugs known to increase intracellular levels of cyllic AMP were studied in the leucocyte migration ihibition system. It was found that cyclic AMP, dibutyryl cyclic AMP, theophyline, and prostaglandins E1 and E2 inhibited the production of leucocyte inhibiting factor by HA pulsed lymphocytes Inhibition only occured when the drugs were present during or after the PHA pulse. In addition it was found that these drugs enhanced the migration of polymorphonuclear leucocytes (PMN), in this system. Electrophoretic mobility of PMN cells was not altered by these drug indicating that the effect is not due to changes in membrane charge. However, granulocyte adhesion was reduced in the presence of these drug suggesting that adhesion is of primary importance in the migration of polymorphonuclear leucocytes out of capillary tubes. The findings show that cyclic AMP is important in modulating both cell-mediated and inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 181189      PMCID: PMC1538516     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  Soluble lymphocytic mediators. I. Inhibition of macrophage migration inhibitory factor production by drugs.

Authors:  E Pick
Journal:  Immunology       Date:  1974-03       Impact factor: 7.397

2.  Role of cyclic AMP in mitogen induced transformation of human peripheral leukocytes.

Authors:  R Krishnaraj; G P Talwar
Journal:  J Immunol       Date:  1973-10       Impact factor: 5.422

3.  Prevention of MIF activity by agents known to increase cellular cyclic AMP.

Authors:  W J Koopman; M H Gillis; J R David
Journal:  J Immunol       Date:  1973-06       Impact factor: 5.422

4.  Cyclic AMP inhibition of cytotoxin ("lymphotoxin") elaboration by stimulated lymphocytes.

Authors:  R B Lies; J B Peter
Journal:  Cell Immunol       Date:  1973-08       Impact factor: 4.868

5.  Cyclic AMP affects macrophage migration.

Authors:  E Pick
Journal:  Nat New Biol       Date:  1972-08-09

6.  Polymorphonuclear leukocyte motility in vitro. VI. Effect of purine and pyrimidine analogues: possible role of cyclic AMP.

Authors:  R L Tse; P Phelps; D Urban
Journal:  J Lab Clin Med       Date:  1972-08

7.  The role of cyclic AMP in the cytolytic activity of lymphocytes.

Authors:  C S Henney; L M Lichtenstein
Journal:  J Immunol       Date:  1971-08       Impact factor: 5.422

8.  Effect of cyclic 3',5'-adenosine monophosphate and theophylline on lymphocyte transformation.

Authors:  R Hirschhorn; J Grossman; G Weissmann
Journal:  Proc Soc Exp Biol Med       Date:  1970-04

9.  Interaction of leukocyte chemotactic factors with the cell surface. I. Chemotactic factor-induced changes in human granulocyte surface charge.

Authors:  J I Gallin; J R Durocher; A P Kaplan
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

10.  Human lymphocytic metabolism. Effects of cyclic and noncyclic nucleotides on stimulation by phytohemagglutinin.

Authors:  J W Smith; A L Steiner; C W Parker
Journal:  J Clin Invest       Date:  1971-02       Impact factor: 14.808

View more
  19 in total

1.  The role of locomotion in lymphocyte migration.

Authors:  A A Freitas; J Bognacki
Journal:  Immunology       Date:  1979-02       Impact factor: 7.397

2.  Stimulation of capillary tube polymorph migration: an indirect glucocorticoid effect on microtubular function.

Authors:  R D Stevenson; A C Gray; N P Lucie
Journal:  Clin Exp Immunol       Date:  1978-09       Impact factor: 4.330

3.  Involvement of prostaglandin E1 in delayed-type hypersensitivity suppression induced with live Mycobacterium bovis BCG.

Authors:  K Kato; K Yamamoto
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

4.  Isolation and purification of human large bowel mucosal lymphoid cells: effect of separation technique on functional characteristics.

Authors:  P W Bland; E R Richens; D C Britton; J V Lloyd
Journal:  Gut       Date:  1979-12       Impact factor: 23.059

5.  In vitro reversal of cellular unresponsiveness induced by levamisole.

Authors:  H Golding; B Golding; R Jacobson; R Lomnitzer; H J Koornhof; A R Rabson
Journal:  Clin Exp Immunol       Date:  1976-11       Impact factor: 4.330

6.  The effect of PHA-activated MN-cell supernatants on polymorphonuclear leucocyte function.

Authors:  R Lomnitzer; A Glover; A R Rabson
Journal:  Clin Exp Immunol       Date:  1977-09       Impact factor: 4.330

7.  Release of the lymphokine osteoclast activating factor requires cyclic AMP accumulation.

Authors:  T Yoneda; G R Mundy
Journal:  Calcif Tissue Int       Date:  1982-03       Impact factor: 4.333

8.  The levels and relations of prostaglandins in pregnant and non-pregnant tumor-bearing mice.

Authors:  H Mujagić; N Krnjajić; A Jevrić
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

9.  Leucocyte capillary migration: an adherence dependent phenomenon.

Authors:  R Lomnitzer; A R Rabson; H J Koornhof
Journal:  Clin Exp Immunol       Date:  1976-08       Impact factor: 4.330

10.  Prostaglandin E2 depresses natural cytotoxicity by inhibiting interleukin-1 production by large granular lymphocytes.

Authors:  J Herman; A R Rabson
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.